TB DRUG MONOGRAPHS
  • Home
  • Baseline & Ongoing Monitoring Tests
  • Drug Monographs
    • Amikacin
    • Bedaquiline
    • Capreomycin
    • Clarithromycin
    • Clofazimine
    • Co-Amoxiclav
    • Cycloserine
    • Delamanid
    • Ethambutol
    • Imipenem/Cilastatin
    • Isoniazid
    • Levofloxacin
    • Linezolid
    • Meropenem
    • Moxifloxacin
    • Ofloxacin
    • P-aminosalicylic acid
    • Pretomanid
    • Prothionamide
    • Pyrazinamide
    • Rifabutin
    • Rifampicin
    • Rifapentine
    • Streptomycin
    • Terizidone
    • Thioacetazone
  • For patients
  • Updates
  • Publications
  • References
  • About Us
  • Contact
Potter JL, Capstick T, Ricketts WM, Whitehead N, Kon OM. A UK-based resource to support the monitoring and safe use of anti-TB drugs and second-line treatment of multidrug-resistant TB. Thorax 2014 doi:10.1136/thoraxjnl-2014-205278A. OPEN ACCESS


The information we have provided here is not exhaustive and is aimed as a practical tool for aid in the management of patients with MDR-TB.  A list of references is included in a separate document however the majority of these recommendations are based on expert consensus.   Feedback is welcomed.  This is a drug monitoring guideline, for treatment guidance please refer to the WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment https://www.who.int/publications/i/item/9789240007048  and the BTS MDR-TB Clinical Advisory Service www.brit-thoracic.org.uk/quality-improvement/lung-disease-registries/bts-mdr-tb-clinical-advice-service/